浙江省应对技术性贸易壁垒信息服务平台
当前位置:首页 > 产业应对 > > TBT通报数据库 > TBT通报详情

通报号:G/TBT/N/CAN/653   英文文本阅览 

中文标题:

咨询通知 - 处方药清单 (PDL):溴莫尼定

英文标题:

Notice of Consultation - Prescription Drug List (PDL): Brimonidine (1 page, available in English and French)

成员国:加拿大

通报日期:2021-09-08

内容概述:

The purpose of this Notice of Consultation is to provide an opportunity to comment on the proposal to revise the listing for brimonidine or its salts, by adding a qualifier to the human and veterinary parts of the Prescription Drug List.